Edition:
United States

China Biologic Products Holdings Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

80.85USD
16 Feb 2018
Change (% chg)

$-2.33 (-2.80%)
Prev Close
$83.18
Open
$82.90
Day's High
$83.11
Day's Low
$80.09
Volume
31,442
Avg. Vol
92,648
52-wk High
$120.01
52-wk Low
$74.01

Chart for

About

China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product... (more)

Overall

Beta: 1.64
Market Cap(Mil.): $2,678.59
Shares Outstanding(Mil.): 33.13
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-China Biologic To Build New Collection Station In Hainan Province

* CHINA BIOLOGIC TO BUILD NEW COLLECTION STATION IN HAINAN PROVINCE

Feb 14 2018

BRIEF-Marc Chan Reports 9.5 Percent Passive Stake In China Biologic Products Holdings As Of Dec 31, 2017

* MARC CHAN REPORTS 9.5 PERCENT PASSIVE STAKE IN CHINA BIOLOGIC PRODUCTS HOLDINGS INC AS OF DEC 31, 2017 - SEC FILING‍​ Source text - (http://bit.ly/2CffxTI) Further company coverage:

Feb 12 2018

BRIEF-China Biologic Receives Operating Permit For New Collection Facility In Ju County In Shandong Province

* CHINA BIOLOGIC RECEIVES OPERATING PERMIT FOR NEW COLLECTION FACILITY IN JU COUNTY IN SHANDONG PROVINCE Source text for Eikon: Further company coverage:

Dec 15 2017

BRIEF-China Biologic posts Q3 adj. earnings per share $1.38

* China Biologic reports unaudited financial results for the third quarter of 2017

Nov 01 2017

BRIEF-China Biologic agrees to acquire Tianxinfu from PWM

* China Biologic Products Holdings Inc - ‍It has agreed to acquire 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co., Ltd​

Oct 12 2017

BRIEF-China Biologic receives approval for commercial manufacturing of human fibrinogen

* China Biologic receives approval for commercial manufacturing of human fibrinogen

Oct 09 2017

Earnings vs. Estimates